Cover Image
市場調查報告書

人類乳突病毒 (HPV) 檢驗的全球市場:2016年∼2020年

Global HPV Testing Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 295876
出版日期 內容資訊 英文 80 Pages
訂單完成後即時交付
價格
Back to Top
人類乳突病毒 (HPV) 檢驗的全球市場:2016年∼2020年 Global HPV Testing Market 2016-2020
出版日期: 2016年12月13日 內容資訊: 英文 80 Pages
簡介

全球人類乳突病毒 (HPV) 檢驗檢驗市場,預計從2016年到2020年,以16.17%的年複合成長率擴大。

本報告提供全球人類乳突病毒 (HPV) 檢驗市場現狀與未來預測,市場成長因素與課題,主要供應商的簡介等。

第1章 摘要整理

  • 概況

第2章 本報告的調查範圍

  • 市場概要
  • 主要供應商的產品

第3章 市場調查手法

  • 調查手法
  • 經濟指標

第4章 簡介

  • 主要市場洞察
  • HPV檢驗的子宮頸癌症的診斷

第5章 市場形勢

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第6章 各產品的市場分類

  • 系統
  • 消耗品

第7章 各終端用戶的市場分類

  • 醫院
  • 臨床檢驗機關
  • 診療所

第8章 地理區分

  • 南北美洲
  • 歐洲、中東、非洲地區
  • 亞太地區

第9章 市場成長因素

第10章 市場成長因素的影響

第11章 市場課題

第12章 成長因素與課題的影響

第13章 市場趨勢

第14章 業者情勢

  • 競爭情形 analysis

第15章 主要供應商分析

  • Abbott Laboratories
  • BD
  • Roche Diagnostics
  • Qiagen
  • Hologic
  • 其他卓越供應商

第16章 附錄

  • 簡稱清單

第17章 關於Technavio

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR11106

About HPV Testing

According to Centers for Disease Control and Prevention (CDC), human papillomavirus (HPV) refers to a group of more than 100 related viruses that commonly cause infections and do not have any symptoms. Among these, more than 40 types of HPVs cause highly contagious diseases that are transmitted through direct sexual contact, infecting both male and female genitals. The other types of HPV cause non-genital warts that are not sexually transmitted. Though most HPV infections are harmless and heal on their own, certain high-risk types of genital HPV can be persistent and cause cervical, penile, anal, vaginal, and oropharyngeal cancers. Many individuals, especially women, undergo regular HPV tests as a preventive measure. HPV tests help to detect the viral genetic material in a cell sample taken from the cervix.

Technavio's analysts forecast the global HPV testing market to grow at a CAGR of 16.17% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global HPV testing market for 2016-2020. To calculate the market size, the report considers only the HPV test products used for genital cancer screening such as cervical cancer.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global HPV Testing Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Abbott Laboratories
  • BD
  • Roche Diagnostics
  • Qiagen

Other Prominent Vendors

  • Arbor Vita
  • Breakspear Medical
  • Cepheid
  • DAAN Gene
  • DiaCarta
  • Delphi Bioscience
  • Fujirebio Diagnostics
  • Genera Biosystems
  • IncellDx
  • OralDNA Labs
  • Seegene
  • SoloPap
  • Trovagene

Market driver

  • Early detection of cervical cancer to prevent the growing prevalence
  • For a full, detailed list, view our report

Market challenge

  • Pap test: Alternative diagnostic tests for cervical cancer screening
  • For a full, detailed list, view our report

Market trend

  • Expansion of companies in key markets
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our procurement specialist's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights
  • Cervical cancer diagnosis by HPV testing

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by product

  • Global HPV testing market by systems
  • Global HPV testing market by consumables

PART 07: Market segmentation by end-user

  • Hospitals
  • Clinical diagnostic laboratories
  • Physicians' office laboratories

PART 08: Geographical segmentation

  • HPV testing market in Americas
  • HPV testing market in EMEA
  • HPV testing market in APAC

PART 09: Market drivers

  • Early detection of cervical cancer to prevent the growing prevalence
  • Paradigm shift toward use of HPV home-testing kits
  • Reimbursements for HPV tests

PART 10: Impact of drivers

PART 11: Market challenges

  • Pap test: Alternative diagnostic test for cervical cancer screening
  • Limited number of health clinics and healthcare settings in developing countries
  • Lack of uniformity in screening policies

PART 12: Impact of drivers and challenges

PART 13: Market trends

  • Expansion of companies in key markets
  • Co-testing with HPV and Pap tests
  • Development of mRNA HPV test

PART 14: Vendor landscape

  • Competitive landscape analysis

PART 15: Key vendor analysis

  • Abbott Laboratories
  • BD
  • Roche Diagnostics
  • Qiagen
  • Hologic
  • Other prominent vendors

PART 16: Appendix

  • List of abbreviations

PART 17: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Market dynamics: Global HPV testing market
  • Exhibit 03: Global HPV testing market 2015-2020 ($ millions)
  • Exhibit 04: Five forces analysis
  • Exhibit 05: Global HPV testing market by product 2015 and 2020
  • Exhibit 06: Market overview: Global HPV testing market by systems
  • Exhibit 07: Global HPV testing market by systems 2015-2020 ($ millions)
  • Exhibit 08: PEST analysis: Global HPV testing market by systems
  • Exhibit 09: Market overview: Global HPV testing market by consumables
  • Exhibit 10: Global HPV testing market by consumables 2015-2020 ($ millions)
  • Exhibit 11: PEST analysis: Global HPV testing market by consumables
  • Exhibit 12: Global HPV testing market by end-users 2015
  • Exhibit 13: Revenue generated by diagnostic and medical laboratories in US 2009-2014 ($ millions)
  • Exhibit 14: Global HPV testing market by geography in 2015 and 2020 ($ millions)
  • Exhibit 15: Americas: Market overview of HPV testing
  • Exhibit 16: Comparative percentage of women aged between 20 and 69 who participated in cervical cancer screening in Americas (2003 and 2013)
  • Exhibit 17: HPV testing market in Americas 2015-2020 ($ millions)
  • Exhibit 18: HPV testing market in Americas: Analysis in various countries
  • Exhibit 19: Key takeaway: HPV testing market in the US
  • Exhibit 20: PEST analysis: HPV testing market in the US
  • Exhibit 21: Differences: HPV testing guidelines for cervical cancer testing
  • Exhibit 22: EMEA: market overview of HPV testing
  • Exhibit 23: Percentage of women aged 20-69 participated in cervical cancer screening in EMEA in different countries (2003 and 2013)
  • Exhibit 24: HPV testing market in EMEA 2015-2020 ($ millions)
  • Exhibit 25: HPV testing market in EMEA: Analysis in various countries
  • Exhibit 26: Key takeaway: HPV testing market in the UK
  • Exhibit 27: PEST analysis: HPV testing market in the UK
  • Exhibit 28: APAC: market overview of HPV testing
  • Exhibit 29: HPV testing market in APAC 2015-2020 ($ millions)
  • Exhibit 30: HPV testing market in EMEA: Analysis in various countries
  • Exhibit 31: Estimated number of cervical cancer in women at different age groups 2014
  • Exhibit 32: Market impact analysis: HPV home-testing kits
  • Exhibit 33: Impact of drivers
  • Exhibit 34: Lack of uniformity in cervical cancer screening intervals in EMEA
  • Exhibit 35: Impact of drivers and challenges
  • Exhibit 36: Market impact analysis: companies in key market
  • Exhibit 37: Market analysis: Companies focusing on mRNA HPV test
  • Exhibit 38: Competitive structure analysis of global HPV testing market 2015
  • Exhibit 39: Competitive landscape analysis of global HPV testing market 2015
  • Exhibit 40: Market penetration of various HPV testing manufacturing companies in global (2015)
  • Exhibit 41: Game changing factors for companies to focus on the market
  • Exhibit 42: Abbott Laboratories strength assessment
  • Exhibit 43: Abbott Laboratories strategy assessment
  • Exhibit 44: Abbott Laboratories opportunity assessment
  • Exhibit 45: BD strength assessment
  • Exhibit 46: BD strategy assessment
  • Exhibit 47: BD opportunity assessment
  • Exhibit 48: Roche Diagnostics strength assessment
  • Exhibit 49: Roche Diagnostics strategy assessment
  • Exhibit 50: Roche Diagnostics opportunity assessment
  • Exhibit 51: Qiagen strength assessment
  • Exhibit 52: Qiagen strategy assessment
  • Exhibit 53: Qiagen opportunity assessment
  • Exhibit 54: Hologic strength assessment
  • Exhibit 55: Hologic strategy assessment
  • Exhibit 56: Hologic opportunity assessment
  • Exhibit 57: Other prominent vendors
  • Exhibit 58: Product matrix: HPV testing market analysis
Back to Top